Zendef 6 Tablet contains Deflazacort 6 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain muscular dystrophies. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue inflammation and immune system overactivity. Zendef 6 is administered orally and should be taken under medical supervision, with dosage tailored to the severity of the condition and patient response. Common side effects may include gastrointestinal discomfort, increased susceptibility to infections, hyperglycemia, and potential adrenal suppression with prolonged use. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Abrupt discontinuation should be avoided to prevent withdrawal symptoms; gradual tapering is recommended. Regular monitoring of blood pressure, blood glucose levels, and bone density may be necessary during extended therapy. Zendef 6 should not be used in patients with systemic fungal infections or known hypersensitivity to corticosteroids. This medication is intended for short-term or carefully monitored long-term use as part of a comprehensive treatment plan.